Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ohr Pharmaceutical Inc | 84,200 | reported | 16 Mar 2023 | tx 6+584,200 |
| Amneal Pharmaceuticals, Inc. | 83,113 | reported | 27 Feb 2020 | tx 9+677,153−191,073 |
| Phathom Pharmaceuticals, Inc. | 60,000 | reported | 28 Jan 2021 | tx 2+145,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2023 | GRANT_AWARD | Ohr Pharmaceutical Inc | 54,200 | 0.00 USD | |
| 03 Nov 2022 | GRANT_AWARD | Ohr Pharmaceutical Inc | 200,000 | 0.00 USD | deriv |
| 18 Mar 2022 | PURCHASE | Ohr Pharmaceutical Inc | 10,000 | 1.81 USD | |
| 17 Mar 2022 | PURCHASE | Ohr Pharmaceutical Inc | 10,000 | 1.74 USD | |
| 16 Mar 2022 | PURCHASE | Ohr Pharmaceutical Inc | 10,000 | 1.62 USD | |
| 10 Jan 2022 | GRANT_AWARD | Ohr Pharmaceutical Inc | 300,000 | 0.00 USD | deriv |
| 28 Jan 2021 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 60,000 | 0.00 USD | deriv |
| 13 Jul 2020 | GRANT_AWARD | Phathom Pharmaceuticals, Inc. | 85,000 | 0.00 USD | deriv |
| 27 Feb 2020 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 166,226 | 0.00 USD | deriv |
| 27 Feb 2020 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 83,113 | 0.00 USD | deriv |
| 22 Jan 2020 | EXERCISE | Amneal Pharmaceuticals, Inc. | 20,096 | — | |
| 22 Jan 2020 | TAX_WITHHOLDING | Amneal Pharmaceuticals, Inc. | 7,311 | 5.13 USD | |
| 22 Jan 2020 | EXERCISE | Amneal Pharmaceuticals, Inc. | 20,096 | 0.00 USD | deriv |
| 13 Nov 2019 | OTHER | Amneal Pharmaceuticals, Inc. | 163,666 | — | deriv |
| 13 Nov 2019 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 163,666 | — | deriv |
| 22 Jan 2019 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 163,666 | 0.00 USD | deriv |
| 22 Jan 2019 | GRANT_AWARD | Amneal Pharmaceuticals, Inc. | 80,386 | 0.00 USD | deriv |